XML 32 R19.htm IDEA: XBRL DOCUMENT v3.3.1.900
INCOME TAXES
3 Months Ended
Jan. 02, 2016
Income Tax Disclosure [Abstract]  
INCOME TAXES
INCOME TAXES
The following table reflects the provision for income taxes and the effective tax rate for the three months ended January 2, 2016 and December 27, 2014
 
Three months ended
(dollar amounts in thousands)
January 2, 2016
 
December 27, 2014
(Loss) / Income from operations before income taxes
$
(1,356
)
 
$
9,685

Income tax (benefit) / expense
(1,265
)
 
1,843

Net (loss) / income
$
(91
)
 
$
7,842

 
 
 
 
Effective tax rate (benefit)
(93.3
)%
 
19.0
%

For the three months ended January 2, 2016, the effective income tax rate differed from the federal statutory tax rate primarily due to profits from foreign operations subject to a lower statutory tax rate than the U.S. statutory tax rate, tax benefits from domestic research expenditures, and the impact of tax holidays, offset by an increase for deferred taxes on unremitted earnings, an increase in valuation allowance against certain foreign deferred tax assets and foreign withholding taxes.
For the three months ended December 27, 2014, the effective income tax rate differed from the federal statutory tax rate primarily due to profits from foreign operations subject to a lower statutory tax rate than the U.S. statutory tax rate, and the impact of tax holidays, offset by an increase for deferred taxes on unremitted earnings, other U.S. deferred taxes and foreign withholding taxes.
The effective tax rate (benefit) for the period ended January 2, 2016 of (93.3)% reflects a year-to-date tax benefit of $(1.3) million on a year-to-date loss of $(1.4) million. The effective tax rate for the period ended December 27, 2014 of 19.0% reflects a year-to-date tax expense of $1.8 million on a year-to-date income of $9.7 million. The tax benefit for the period ended January 2, 2016 of $(1.3) million differed from the tax expense for the period ended December 27, 2014 of $1.8 million was primarily due to higher profits in foreign jurisdiction with lower tax rate and an increase in tax benefit from research and development expenditures. On December 18, 2015, the U.S. federal research tax credits have been permanently extended which resulted in the Company recording a discrete tax benefit for the period ended January 2, 2016.
The Company's future effective tax rate would be affected if earnings were lower than anticipated in countries where it has lower statutory rates and higher than anticipated in countries where it has higher statutory rates, by changes in the valuation of its deferred tax assets and liabilities, or by changes in tax laws, regulations, accounting principles, or interpretations thereof. In addition, changes in assertion for foreign earnings permanently or non-permanently reinvested as a result of changes in facts and circumstances could significantly impact the effective tax rate. The Company regularly assesses the effects resulting from these factors to determine the adequacy of its provision for income taxes.
It is reasonably possible that the amount of the unrecognized tax benefit with respect to certain unrecognized tax positions will increase or decrease during the next 12 months due to the expected lapse of statutes of limitation and / or settlements of tax examinations. The Company is currently under income tax examination by tax authorities in certain foreign jurisdictions.